Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Crosby

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 2001
Muscarinic agonists and antagonists in the treatment of Alzheimer's diseaseW Greenlee, J Clader, T Asberom, et al.
Psychological Medicine|June 27, 2008
Anorexia nervosa trios: behavioral profiles of individuals with anorexia nervosa and their parentsM J Jacobs, S Roesch, S A Wonderlich, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2020
P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognitionEdwin Vázquez-Rosa, Min-Kyoo Shin, Matasha Dhar, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Msystems|June 1, 2021
Transcriptional Regulation of Plant Biomass Degradation and Carbohydrate Utilization Genes in the Extreme Thermophile <i>Caldicellulosiruptor bescii</i>Dmitry A Rodionov, Irina A Rodionova, Vladimir A Rodionov, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
American Journal of Human Genetics|February 11, 2014
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacksGina M Peloso, Paul L Auer, Joshua C Bis, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2019
A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer ImmunotherapyEmily J Pomeroy, John T Hunzeker, Mitchell G Kluesner, et al.
Oncogene|October 5, 2019
SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasisBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 2001
Muscarinic agonists and antagonists in the treatment of Alzheimer's diseaseW Greenlee, J Clader, T Asberom, et al.
Psychological Medicine|June 27, 2008
Anorexia nervosa trios: behavioral profiles of individuals with anorexia nervosa and their parentsM J Jacobs, S Roesch, S A Wonderlich, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2020
P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognitionEdwin Vázquez-Rosa, Min-Kyoo Shin, Matasha Dhar, et al.
Bone|April 7, 2020
PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcomaBranden A Smeester, Nicholas J Slipek, Emily J Pomeroy, et al.
Msystems|June 1, 2021
Transcriptional Regulation of Plant Biomass Degradation and Carbohydrate Utilization Genes in the Extreme Thermophile <i>Caldicellulosiruptor bescii</i>Dmitry A Rodionov, Irina A Rodionova, Vladimir A Rodionov, et al.
Molecular Cancer Therapeutics|October 1, 2020
Implication of <i>ZNF217</i> in Accelerating Tumor Development and Therapeutically Targeting ZNF217-Induced PI3K-AKT Signaling for the Treatment of Metastatic OsteosarcomaBranden A Smeester, Garrett M Draper, Nicholas J Slipek, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 23, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLCHua Zhang, Christopher S Nabel, Dezhi Li, et al.
American Journal of Human Genetics|February 11, 2014
Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacksGina M Peloso, Paul L Auer, Joshua C Bis, et al.
Pageof 18